Application of the International Classification of Functioning, Disability and Health in children with neurofibromatosis type 1: A review

Developmental Medicine and Child Neurology

Volumn 52, Issue 7, 2010, Pages 612-619

  Gilboa, Yafit ^a   Rosenblum, Sara ^a   Fattal Valevski, Aviva ^b   Josman, Naomi ^a  

^a UNIVERSITY OF HAIFA   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION; CAFE AU LAIT SPOT; CHILD; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; ENVIRONMENTAL FACTOR; FUNCTIONAL ASSESSMENT; HUMAN; INTELLECTUAL IMPAIRMENT; INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH; INTERPERSONAL COMMUNICATION; LANGUAGE ABILITY; LEARNING; MEMORY; NEUROFIBROMATOSIS; NEUROMUSCULAR FUNCTION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SELF ESTEEM; SOCIAL ASPECT;

CHILD; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; LEARNING; MENTAL DISORDERS; MENTAL PROCESSES; NEUROFIBROMATOSIS 1; QUALITY OF LIFE;

EID: 77954640736     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2010.03624.x     Document Type: Review

References (70)

1. Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet 1999, 89:1-6.
2. Tonsgard JH. Clinical manifestations and management of neurofibromatosis type 1. Semin Pediatr Neurol 2006, 13:2-7.
3. Ward BA, Gutmann DH. Neurofibromatosis 1: from lab bench to clinic. Pediatr Neurol 2005, 32:221-8.
4. North K. Neurofibromatosis type 1. Am J Med Genet 2000, 97:119-27.
5. International Classification of Functioning, Disability and Health - Children and Youth Version (ICF-CY) 2007, Geneva, World Health Organization
6. International Classification of Functioning, Disability and Health (ICF) 2001, Geneva, World Health Organization
7. Maes S, Bruil J. Assessing quality of life of children with a chronic illness. Health Psychology and Quality of Life Research 1995, 637-52. Rodriguez-Marin J, In, editor, Alicante, Spain, Health Psychology Department, University of Alicante
8. Shelly A, Davis E, Waters E. The relationship between quality of life and functioning for children with cerebral palsy. Dev Med Child Neurol 2008, 50:199-203.
9. Livingston MH, Rosenbaum PL, Russell DJ, Palisano RJ. Quality of life among adolescents with cerebral palsy: what does the literature tell us? Dev Med Child Neurol 2007, 49:225-31.
10. Matsuda T, Noguchi M, Umeno Y, Kato N. QoL research in child health. Present state and issues. Nippon Koshu Eisei Zasshi 2006, 53:805-17. [In Japanese]
11. Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty-first century perspective. Lancet Neurol 2007, 6:340-51.
12. Levine TM, Materek A, Abel J, O'Donnell M, Cutting LE. Cognitive profile of neurofibromatosis type 1. Semin Pediatr Neurol 2006, 13:8-20.
13. Oostenbrink R, Spong K, de Goede-Bolder A, Landgraf JM, Raat H, Moll HA. Parental reports of health-related quality of life in young children with neurofibromatosis type 1: influence of condition specific determinants. J Pediatr 2007, 151:182-6.
14. Page PZ, Page GP, Ecosse E, Korf BR, Leplege A, Wolkenstein P. Impact of neurofibromatosis 1 on quality of life: a cross-sectional study of 176 American cases. Am J Med Genet A 2006, 140:1893-8.
15. Wolkenstein P, Rodriguez D, Ferkal S. Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases. Br J Dermatol 2009, 160:844-8.
16. Krab LC, Oostenbrink R, de Goede-Bolder A, Aarsen FK, Elgersma Y, Moll HA. Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior. J Pediatr 2009, 154:420-5.
17. Hyman SL, Shores A, North KN. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 2005, 65:1037-44.
18. Acosta MT, Gioia GA, Silva AJ. Neurofibromatosis type 1: new insights into neurocognitive issues. Curr Neurol Neurosci Rep 2006, 6:136-43.
19. Belzeaux R, Lançon C. Neurofibromatosis type 1: psychiatric disorders and quality of life impairment [article in French]. Presse Med 2006, 35:277-80.
20. Descheemaeker MJ, Ghesquière P, Symons H, Fryns JP, Legius E. Behavioural, academic and neuropsychological profile of normally gifted neurofibromatosis type 1 children. J Intellect Disabil Res 2005, 49:33-46.
21. Koth CW, Cutting LE, Denckla MB. The association of neurofibromatosis type 1 and attention deficit hyperactivity disorder. Child Neuropsychol 2000, 6:185-94.
22. North K, Hyman S, Barton B. Cognitive deficits in neurofibromatosis 1. J Child Neurol 2002, 17:605-12.
23. Schunk DH. Self-efficacy and academic motivation. Educ Psychol 1991, 26:207-31.
24. Benjamin CM, Colley A, Donnai D, Kingston H, Harris R, Kerzin-Storrar L. Neurofibromatosis type 1 (NF1): knowledge, experience, and reproductive decisions of affected patients and families. J Med Genet 1993, 30:567-74.
25. Barton B, North K. The self-concept of children and adolescents with neurofibromatosis type 1. Child Care Health Dev 2007, 33:401-8.
26. Counterman AP, Saylor CF, Pai S. Psychological adjustment of children and adolescents with neurofibromatosis. Child Health Care 1995, 24:223-34.
27. Dilts CV, Carey JC, Kircher JC. Children and adolescents with neurofibromatosis 1: a behavioral phenotype. J Dev Behav Pediatr 1996, 17:229-39.
28. Ferner RE, Hughes RA, Weinman J. Intellectual impairment in neurofibromatosis 1. J Neurol Sci 1996, 138:125-33.
29. Kayl AE, Moore BD. Behavioral phenotype of neurofibromatosis, type 1. Ment Retard Dev Disabil Res Rev 2000, 6:117-24.
30. Eliason MJ. Neurofibromatosis: implications for learning and behavior. J Dev Behav Pediatr 1986, 7:175-9.
31. Ylvisaker M, Feeney T. Executive functions, self-regulation, and learned optimism in paediatric rehabilitation: a review and implications for intervention. Pediatr Rehabil 2002, 5:51-70.
32. Hofman KJ, Harris EL, Bryan RN, Denckla MB. Neurofibromatosis type 1: the cognitive phenotype. J Pediatr 1994, 124:S1-8.
33. Rowbotham I, Pit-ten Cate IM, Sonuga-Barke EJ, Huijbregts SC. Cognitive control in adolescents with neurofibromatosis type 1. Neuropsychology 2009, 23:50-60.
34. Chapman CA, Waber DP, Bassett N, Urion DK, Korf BR. Neurobehavioral profiles of children with neurofibromatosis 1 referred for learning disabilities are sex-specific. Am J Med Genet 1996, 67:127-32.
35. Ozonoff S. Cognitive impairment in neurofibromatosis type 1. Am J Med Genet 1999, 89:45-52.
36. Bennett TL. Neuropsychological evaluation in rehabilitation planning and evaluation of functional skills. Arch Clin Neuropsychol 2001, 16:237-53.
37. Sbordone RJ. Ecological validity: some critical issues for the neuropsychologist. Ecological Validity of Neuropsychological Testing 1996, 15-42. Sbordone RJLong CJ. In, editors, Boca Raton, FL, USA, GR Press/St Lucie Press (CRC Press)
38. Lehnert G, Zimmer HD. Modality and domain specific components in auditory and visual working memory tasks. Cogn Process 2008, 9:53-61.
39. Varnhagen CK, Lewin S, Das JP, Bowen P, Ma K, Klimek M. Neurofibromatosis and psychological processes. J Dev Behav Pediatr 1988, 9:257-65.
40. Billingsley RL, Slopis JM, Swank PR, Jackson EF, Moore BD. Cortical morphology associated with language function in neurofibromatosis, type I. Brain Lang 2003, 85:125-39.
41. Joy P, Roberts C, North K, de Silva M. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1. Dev Med Child Neurol 1995, 37:906-14.
42. Hyman SL, Arthur Shores E, North KN. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Dev Med Child Neurol 2006, 48:973-7.
43. Benton AL, Varney NR, Hamsher K. Judgment of Line Orientation 1976, Iowa City, IA, USA, Department of Neurology, University of Iowa
44. Cutting LE, Clements AM, Lightman AD, Yerby-Hammack PD, Denckla MB. Cognitive profile of neurofibromatosis type 1: rethinking nonverbal learning disabilities. Learn Disabil Res Pract 2004, 19:155-65.
45. Pikus AT. Pediatric audiologic profile in type 1 and type 2 neurofibromatosis. J Am Acad Audiol 1995, 6:54-62.
46. Geist RT, Gutmann DH. Expression of a developmentally-regulated neuron-specific isoform of the neurofibromatosis 1 (NF1) gene. Neurosci Lett 1996, 211:85-8.
47. Billingsley RL, Schrimsher GW, Jackson EF, Slopis JM, Moore BD. Significance of planum temporale and planum parietale morphologic features in neurofibromatosis type 1. Arch Neurol 2002, 59:616-22.
48. Hyman SL, Gill DS, Shores EA. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1. Neurology 2003, 60:1139-45.
49. Mazzocco MMM, Turner JE, Denckla MB, Hofman KJ, Scanlon DC, Vellutino FR. Language and reading deficits associated with neurofibromatosis type 1: evidence for a not-so-nonverbal learning disability. Dev Neuropsychol 1995, 11:503-22.
50. Schneck CM. Visual perception. Occupational Therapy for Children 1996, 329-81. Case-Smith JAllen APratt PN. In, editors, 3rd edn, St Louis, MO, USA, Mosby
51. Krab LC, Aarsen FK, de Goede-Bolder A. Impact of neurofibromatosis type 1 on school performance. J Child Neurol 2008, 23:1002-10.
52. Coudé FX, Mignot C, Lyonnet S, Munnich A. Early grade repetition and inattention associated with neurofibromatosis type 1. J Atten Disord 2007, 11:101-5.
53. Collective Perspectives on Issues Affecting Learning Disabilities: Position Papers and Statements 1994, Austin, TX, USA, Pro-Ed
54. North K, Joy P, Yuille D, Cocks N, Hutchins P. Cognitive function and academic performance in children with neurofibromatosis type 1. Dev Med Child Neurol 1995, 37:427-36.
55. Cutting LE, Koth CW, Burnette CP, Abrams MT, Kaufmann WE, Denckla MB. Relationship of cognitive functioning, whole brain volumes, and T2-weighted hyperintensities in neurofibromatosis-1. J Child Neurol 2000, 15:157-60.
56. Billingsley RL, Jackson EF, Slopis JM, Swank PR, Mahankali S, Moore BD. Functional MRI of visual-spatial processing in neurofibromatosis, type I. Neuropsychologia 2004, 42:395-404.
57. North K, Joy P, Yuille D. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology 1994, 44:878-83.
58. Moore BD, Ater JL, Needle MN, Slopis J, Copeland DR. Neuropsychological profile of children with neurofibromatosis, brain tumor, or both. J Child Neurol 1994, 9:368-77.
59. Rourke BP. Nonverbal Learning Disabilities: The Syndrome and the Model 1989, New York, NY, USA, The Guilford Press
60. Hamstra-Bletz L, Blöte AW. A longitudinal study of dysgraphic handwriting in primary school. J Learn Disabil 1993, 26:689-99.
61. Weintraub N, Drory-Asayag A, Dekel R, Jokobovits H, Parush S. Developmental trends in handwriting performance among middle school children. OTJR Occup Particip Health 2007, 27:104-13.
62. Rosenblum S, Parush S, Weiss PL. Computerized temporal handwriting characteristics of proficient and non-proficient handwriters. Am J Occup Ther 2003, 57:129-38.
63. Lorch M, Ferner RE, Golding J, Whurr R. The nature of speech and language impairment in adults with neurofibromatosis. J Neurolinguistics 1999, 12:157-65.
64. Lorch MP. Disorders of writing and spelling. Handbook of Neurological Speech and Language Disorders 1995, 295-324. Kirschner H. In, editor, New York, NY, USA, Marcel Dekker
65. Barton B, North K. Social skills of children with neurofibromatosis type 1. Dev Med Child Neurol 2004, 46:553-63.
66. Graf A, Landolt MA, Mori AC, Boltshauser E. Quality of life and psychological adjustment in children and adolescents with neurofibromatosis type 1. J Pediatr 2006, 149:348-53.
67. Johnson NS, Saal HM, Lovell AM, Schorry EK. Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions. J Pediatr 1999, 134:767-72.
68. Prinzie P, Descheemaeker MJ, Vogels A. Personality profiles of children and adolescents with neurofibromatosis type 1. Am J Med Genet A 2003, 118A:1-7.
69. Reiter-Purtill J, Schorry EK, Lovell AM, Vannatta K, Gerhardt CA, Noll RB. Parental distress, family functioning, and social support in families with and without a child with neurofibromatosis 1. J Pediatr Psychol 2008, 33:422-34.
70. Rizzo AA, Bowerly T, Buckwalter JG, Klimchuk D, Mitura R, Parsons TD. A virtual reality scenario for all seasons: the virtual classroom. CNS Spectr 2006, 11:35-44.